SCHEMBL22378398

SCHEMBL22378398

N#Cc1c(-c2ccc(-c3ccccc3-n3c4ccccc4c4ccccc43)cc2)ccc(-n2c3ccccc3c3ccccc32)c1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE9A O76083 1/20 0.36
PDE1C Q14123 1/20 0.36
ALDH1A1 P00352 4/20 0.36
PARP1 P09874 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
EGFR P00533 1/20 0.34
SRC P12931 1/20 0.34
HIF1A Q16665 1/20 0.34
CYP11B2 P19099 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
KMT2A Q03164 1/20 0.32
PDCD1 Q15116 3/20 0.31
CD274 Q9NZQ7 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22378797 0.93 SMN1; SMN2 (0.39) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL22377689 0.91 SMN1; SMN2 (0.37) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL22377982 0.90 PDCD1 (0.35) PDE9APDE1CALDH1A1PARP1PDCD1
SCHEMBL22379625 0.90 PDCD1 (0.35) PDE9APDE1CALDH1A1PARP1PDCD1
SCHEMBL19755320 0.90 ALDH1A1 (0.38) KDM4EATML3MBTL1ALDH1A1PARP1
SCHEMBL22377515 0.89 KDM4E (0.41) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL22377454 0.88 ALDH1A1 (0.37) KDM4EATML3MBTL1ALDH1A1PARP1
SCHEMBL24927612 0.86 PDE9A (0.42) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL29107412 0.85 SMN1; SMN2 (0.47) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL22379431 0.84 SMN1; SMN2 (0.40) KDM4EATML3MBTL1PDE9APDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.